Press Releases

• PAL joins "friend of the Court" brief supporting new U.S. Patent Rules 12/20/2007
• PAL Applauds Federal Court Damages Decision in AWP Case 11/02/2007
• PAL & 26 organizations submit comments to FDA on drug ad study 10/19/2007
• Judge Allows Zyprexa Class Action to Go Forward, Says Courts are “in the Strongest Position” to Protect Public from Fraudulent Drug Marketing 06/28/2007
• Federal Court Rules Against Three Drug Companies in Average Wholesale Price Case 06/21/2007
• PAL Announces First Bitter Pill Award of 2007 to GlaxoSmithKline: 'With Allies Like This, Who Needs Enemas?’Award 06/07/2007
• PAL and Public Citizen Secure Improved Settlement for Parents of Children Who Were Prescribed Paxil PAL and Public Citizen Secure Improved Settlement for Parents of Children Who Were Prescribed Paxil 05/08/2007
• PAL and 20 Organizations support Rush-Waxman bill to end Drug Industry Payoffs 04/17/2007
• PAL files objection to $63M Paxil Pediatric Settleent PAL criticizes Illinois state court settlement as not "fair, reasonable or in the best interests of the class." 02/27/2007
• PAL & AFSCME DC 37 announce $24 million settlement with Serono in case alleging illegal promotion of AIDS drug Serostim EMD Serono, Inc. and Merck Serono International S.A. agree to settle class action lawsuit alleging deceptive marketing of drug for AIDS wasting 02/20/2007
• PAL Announces Major Settlement with First Databank Settlement of conspiracy case forces major restructuring of prescription drug pricing system 10/06/2006
• Average Wholesale Price GSK Settlement Landmark settlement could signal the end of prescription drug price-fixing scheme 08/10/2006
• Union Fund Sues Drug Company Over Deceptive Marketing of AIDS Drug Alleges promotional scheme caused members to use anti-wasting drug unnecessarily 05/01/2006
• Top Drug Companies Receive "Honors" For Overhyped Marketing: 2006 Bitter Pill Award Winners Announced 04/26/2006
• Consumer Advocates Call on FDA to Ban Prescription Drugs "Coupons” 04/10/2006
• Female and Elder Consumers and Payers Sue Pfizer Over Deceptive Marketing of Lipitor® Plaintiffs allege promotional scheme to boost sales of world's best-selling drug by misleading women and seniors about link between the drug and heart disease 09/28/2005
• National Consumer Coalition Criticizes Drug Industry Advertising Guidelines as “Toothless and Inadequate” Says self-regulation will not protect consumers from dangers of deceptive advertising 07/22/2005
• Court's decision deals setback to Abbott Laboratories National consumer coalition demands that Abbott stop forcing consumers to pay exhorbitant prices in its grab for market shar and profits. 03/11/2005
• Announcing the Recipients of "The Bitter Pill Awards” Exposing Drug Company Manipulation of Consumers While the Pharmaceutical Marketing Industry Gives Itself Awards for a Banner Year of Pitching Drugs to the Public, Consumer Group Hosts Counter-Awards Exposing Industry Manipulation 03/01/2005
• Massachusetts Consumers Sue Pharmaceutical Company AstraZenaca Over Misleading Nexium® Campaign Consumer groups allege scheme to deceive consumers and reap unfair profits 01/26/2005
• TAP Pharmaceuticals to Pay $150 Million to Settle With Victims of Lupron Scheme 12/01/2004
• Consumers Sue Pharmaceutical AstraZeneca Over Misleading Nexium Campaign AFL-CIO joins suit alleging scheme to deceive consumers, increase profits 10/18/2004
• Consumers and Third Party Payors Reach $29 Million Settlement with GlaxoSmithKline in Antitrust Drug Lawsuit Agreement Requires $29 million to be repaid for Overcharges on Popular Antibiotic 07/09/2004
• Consumer lawsuit charges that Abbott Laboratories’ 400% price hike for essential AIDS drug violates consumer fraud law National coalition accuses Abbott of forcing consumers to pay exorbitant prices or suffer physical harm by switching to lower-priced drug 05/20/2004
• Consumers Reach $75 Million Settlement With GlaxoSmithKline 04/24/2004
• Federal Court Permits Consumer Charges of Rx Industry-Wide Price Fixing and Conspiracy To Procee Judge Lets Stand Conspiracy Charges on Together Rx Discount Card 02/26/2004
• OxyContin Maker Used Deceit, Stalling Tactics to Block Generic Drugs and Gouge Consumers, According to Consumer Lawsuit Exclusive Rights to Drug Reaps Billions in Profits for Company at Expense of Patients Seeking Relief from Pain 01/06/2004
• Consumers Accuse Maker of Hormone Replacement Therapy Drug Estratest of End-Run Around FDA Regulations Seniors Say Company Illegally Sells and Promotes Unapproved Drug at Expense of Consumers’ Health and Pocketbook 08/07/2003
• Consumer Groups Settle Case Against Bristol-Myers Agreement Requires $42 Million Returned to Consumers Nationwide & "Unprecedented" Injunctive Relief 04/09/2003
• Pharmacy Benefit Managers Charged with Inflating Prescription Drug Prices Lawsuit Alleges Secret Deals between PBMs & Pharmaceutical Companies 03/18/2003
• Consumer Groups Accuse Makers of Epilepsy Drug Neurontin of End-Run Around FDA Regulations Lawsuit says companies illegally promoted unapproved use 02/04/2003
• Consumers Accuse Maker of Arthritis Drug BEXTRA of End-Run Around FDA Regulations Suit Charges Purchased Research Promotes Drug at Expense of Consumers’ Health and Pocketbook. Seniors Say Company Illegally Promoted Unapproved Use of Drug 12/23/2002
• Organized Labor Joins Litigation Battle For Fair Drug Prices AFSCME Joins PAL in Two Lawsuits Targeting Drug Companies for Patent Manipulation 10/09/2002
• Consumer Groups Charge Maker of Popular, Over-the-Counter Diarrhea Drug With Illegally Blocking Access to Lower-Priced Generic McNeil Targeted for Manipulating Patent Law on Imodium Advanced 07/09/2002
• Nationwide Coalition of Consumer Groups Welcomes AARP to Class-Action Pharmaceutical Litigation 05/29/2002
• Consumer Groups Charge Drug Company Created Fraudulent Marketing Scheme To Generate Millions in Illegal Profits on Crucial Arthritis Drug Johnson & Johnson Subsidiary Encouraged Physicians to Overbill Medicare and Medicare Patients, Suit Charges 04/12/2002
• Consumer Groups Charge Industry-Wide Price Manipulation – Over $800 Million in Illegal Profits from Medicare & Medicare Patients Federal Lawsuit Charges 28 Drug Companies with RICO, State and Federal Anti-Trust, and Consumer Protection Violations 12/20/2001
• Unlawful Conspiracy Restricted Production of Cipro, Consumers Charge in Suit Filed Today Against Bayer Corporation Bayer Paid Competitors $200mm to Keep Generic Cipro Off the Market; Suit Asks Court to Intercede, Nullify Agreement and Open the Way For Generics to Enter the Market 10/24/2001
• Consumer Groups Sue Over Direct-to-Consumer Advertising by Schering-Plough Maker of Claritin Misleads the Public and Illegally Inflates Prices, Complaint Alleges 08/09/2001
• Consumer Groups Sue Three Drug Companies For Blocking Generic Version of Widely Used Potassium Supplement Suits Charge Schering -Plough, Upsher-Smith Labs & American Home Products Entered Illegal Agreements to Maintain Artificially High Prices of K -DUR20 06/07/2001
• Consumer Groups Charge Price Collusion on Key Breast Cancer Drug Class Actions Say Barr Laboratories, AstraZeneca Illegally Exclude Competition, Maintain Artificially High Prices and Block the Introduction of Generic Tamoxifen 05/09/2001
• Consumer Groups File Class Actions Against Bristol-Myers Squibb Federal and State Lawsuits Charge Bristol-Myers Has “Locked” Generic Version of BuSpar Out of the Market 04/08/2001